U.S. Federal regulators are reviewing data on the link between Moderna’s coronavirus vaccine and a rare heart problem in adolescents, the company announced Sunday. That side effect — myocarditis, an inflammation of the heart muscle — has also worried advisers to federal agencies in deliberations regarding use of the Pfizer-BioNTech vaccine in younger children and teenagers.
Scientists advising the Centers for Disease Control and Prevention will review the latest data on the condition at a meeting Tuesday before deciding whether to recommend the Pfizer-BioNTech vaccine for younger children.
So how common is myocarditis, really? And should parents be concerned about vaccinating their children?
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.